Signant Health: acquisition of VirTrial
Signant Health has purchased VirTrial, a company offering software programs for remote site startup and decentralized trial operation. With the acquisition, Signant Health reportedly expects to enhance the digital performance of trial sites and enable sponsors to more effectively collect data.
Roger Smith, CEO of Signant Health, said, “COVID-19 has created a widespread and urgent need for contingency planning in clinical trial operations and has forever changed how our industry plans and executes trials. Signant and VirTrial are passionate about supporting the trial ecosystem with software, analytics, and logistics solutions to conduct studies and generate data across all modalities while improving, respecting, and honoring the role investigators and coordinators play in collaborating with patients to advance clinical research.”
